Identification of Pathogenic Bacteria of Diabetes Foot Ulcer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai Jiao Tong University School of Medicine

About this trial

The objective of this study is to design and develop a gene chip for detecting pathogenic bacteria in diabetic foot infection wounds. This innovative gene chip technology enables rapid and accurate identification of pathogens at the site of infection by detecting the 16SrDNA sequence of pathogenic bacteria.

Diabetic foot infection is a common serious complication in diabetic patients, often accompanied by complex pathogenic bacteria population, and due to the variety of infection types, traditional pathogen detection methods are time-consuming and low accuracy, patients may miss the best treatment opportunity. Now commonly used genetic identification of pathogenic bacteria often find a variety of bacteria, resulting in the actual pathogenic bacteria difficult to judge.

Eligibility criteria

Qualifiers

Age ≥ 18 years old

Gender: males and females

Patients diagnosed with diabetic foot infection with an infected wound

It can provide sufficient infected wound samples (≥5mm³ infected wound tissue samples or ≥100μL infected wound secretions) and can be used for detection and analysis of gene chips

Disqualifiers

Patients with undiagnosed diabetic foot infection

Patients who had received antibiotics within 4 weeks prior to sampling

Complicated with serious systemic disease (e.g., malignant tumor, severe cardiopulmonary insufficiency, etc.)

Pregnant or lactating women

Trial design

Treatments tested in this trial

  • The infected wound of the patient's foot ulcer was collected

Treatment groups

No treatment groups listed

Sponsors and collaborators